- Home
- NWG vs EW Comparison
NWG vs EW Comparison
Compare NWG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWG | EW |
|---|---|---|
| Founded | 1727 | 1958 |
| Country | United Kingdom | United States |
| Employees | 58700 | N/A |
| Industry | Commercial Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.6B | 49.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | NWG | EW |
|---|---|---|
| Price | $17.96 | $94.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 21 |
| Target Price | N/A | ★ $96.37 |
| AVG Volume (30 Days) | ★ 5.9M | 4.1M |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $14.83 | $13.39 |
| Revenue Next Year | $7.43 | $9.81 |
| P/E Ratio | ★ $18.92 | $142.91 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $13.16 | $72.30 |
| 52 Week High | $19.36 | $94.47 |
Technical Indicators
Market Signals| Indicator | NWG | EW |
|---|---|---|
| Relative Strength Index (RSI) | 68.78 | 70.11 |
| Support Level | $14.78 | $82.02 |
| Resistance Level | $18.19 | N/A |
| Average True Range (ATR) | 0.30 | 2.37 |
| MACD | 0.11 | 0.51 |
| Stochastic Oscillator | 90.03 | 99.12 |
Price Performance
Historical ComparisonAbout NWG NatWest Group plc (each representing two (2))
NatWest Group derives around 90% of its total income from the United Kingdom. The bank operates a retail, commercial, and private bank in the UK, offering clients lending and payment services as well as asset management services.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.